论文部分内容阅读
[目的]探讨胃癌患者营养风险和相应营养支持与患者近期预后和远期生存期的关系.[方法]95例胃癌患者入院即刻给予营养风险评估,记录术后营养支持情况,分析患者术前营养风险状况、术后营养支持与并发症、近远期疗效的关系.[结果]95例胃癌患者有营养风险者占66.32%(63/95),其中接受营养支持者为43例,占68.25%(43/63),营养支持方式为肠外营养支持(PN)18例(28.57%),为PN和肠内营养支持(EN)者25例(39.68%);有营养风险胃癌患者并发症发生率为42.86%,3年病死率为31.75%,3年肿瘤转移复发率为36.51%,均分别高于无营养风险者的21.88%、12.5%、15.63%,其差异有显著性(P<0.05);有营养风险接受营养支持者客观缓解率高于,并发症发生率,3年病死率,3年复发转移率低于有营养风险而无营养支持者,其差异均有显著性(P<0.05).[结论]胃癌患者术前注重营养风险评估并给予相应营养支持,可显著降低并发症发生率,改善预后.“,”[Objective]To investigate the relationship between nutritional risk,nutritional support and short-term prognosis and long-term survival time in patients with gastric cancer.[Methods]Ninety-five cases of gastric cancer patients were given immediate assessment of nutritional risk after admission,and the status of nutritional support was recorded.The relationship between preoperative nutritional risk,postoperative nu-tritional support and complications and short-term efficacy was analyzed.[Results]There were 66.32% cases of nutritional risk in 95 patients with gastric cancer(63/95).Among them,43 patients received nutritional support,accounting for 68.25%(43/63).The nutritional support was performed through parenteral nutrition support(PN)in 18 patients(28.57%),PN and enteral nutrition support(EN)in 25 patients(39.68%);The incidence of complications in patients with nutritional risk of gastric cancer was 42.86%.The mortality rate of 3 year was 31.75%,and 3-year recurrence rate of tumor metastasis was 36.51%,which were higher than those without nutritional risk,21.88%,12.5%,15.63%,and the difference was significant(P<0.05).Patients with nutritional risk and nutritional support got higher objective relief rate than those with non nutritional sup-porters.The complication rate,the 3 year mortality rate,the 3 year recurrence and metastasis rate were lower than those with nutritional risk but without nutritional support,and the difference was significant(P<0.05).[Conclusion]Preoperative nutritional risk assessment and nutritional support can significantly reduce the inci-dence of complications and improve prognosis in patients with gastric cancer.